This is a prospective pilot study investigating the safety and efficacy of stereotactic body radiation therapy (SBRT) as a treatment for breast cancer in patients who do not get surgery. The study will accrue 15 patients who will be treated to a dose of 40 Gy over the course of 5 fractions in the Stony Brook University Hospital Department of Radiation Oncology. The subjects will then have a follow up time of 5 years.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
15
fractionated linear accelerator based SBRT to 40 Gy in 5 fractions
Stony Brook University Hospital
Stony Brook, New York, United States
Rates of acute and late adverse events grade 3 or greater
Rates of acute and late grade 3 or greater toxicity
Time frame: 5 years
Partial and complete response rate by clinical and radiographic response
Time frame: 5 years
Survival
Progression-free survival and overall survival
Time frame: 5 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.